SPANXC
gene geneOn this page
Also known as CTp11CT11.3
Summary
SPANXC (SPANX family member C, HGNC:14331) is a protein-coding gene on chromosome Xq27.2, encoding Sperm protein associated with the nucleus on the X chromosome C (Q9NY87).
Temporally regulated transcription and translation of several testis-specific genes is required to initiate the series of molecular and morphological changes in the male germ cell lineage necessary for the formation of mature spermatozoa. This gene is a member of the SPANX family, which is located in a gene cluster on chromosome X. The SPANX genes encode differentially expressed testis-specific proteins that localize to various subcellular compartments. This particular gene encodes a protein that localizes to the nucleus and is expressed in highly metastatic cell lines, making the protein a potential diagnostic and prognostic marker. The protein belongs to a family of cancer/testis antigens and represents a potential target for cancer immunotherapy.
Source: NCBI Gene 64663 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_022661
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14331 |
| Approved symbol | SPANXC |
| Name | SPANX family member C |
| Location | Xq27.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CTp11, CT11.3 |
| Ensembl gene | ENSG00000198573 |
| Ensembl biotype | protein_coding |
| OMIM | 300330 |
| Entrez | 64663 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000358993
RefSeq mRNA: 1 — MANE Select: NM_022661
NM_022661
CCDS: CCDS14673
Canonical transcript exons
ENST00000358993 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001881872 | 141241463 | 141241738 |
| ENSE00001907049 | 141242386 | 141242517 |
Expression profiles
Bgee: expression breadth broad, 39 present calls, max score 95.32.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0222 / max 11.4296, expressed in 6 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 200746 | 0.0222 | 6 |
Top tissues by expression
99 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 95.32 | gold quality |
| testis | UBERON:0000473 | 72.86 | gold quality |
| left testis | UBERON:0004533 | 72.47 | gold quality |
| right testis | UBERON:0004534 | 67.05 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 46.33 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 35.60 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| muscle tissue | UBERON:0002385 | 32.69 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 31.30 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 29.16 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| endocervix | UBERON:0000458 | 28.57 | silver quality |
| uterine cervix | UBERON:0000002 | 28.51 | silver quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| right lobe of liver | UBERON:0001114 | 27.77 | silver quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| urinary bladder | UBERON:0001255 | 27.31 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| leukocyte | CL:0000738 | 26.70 | silver quality |
| monocyte | CL:0000576 | 26.61 | silver quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| muscle of leg | UBERON:0001383 | 26.53 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.24 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 6)
- SPANXC was found in ejaculated spermatozoa and spermatids. (PMID:15139967)
- genetic variability of SPANX-B & SPANX-C in a sample of Sicilian male population including patients with cutaneous melanoma; statistical significant difference for a particular class of SPANX-C gene was found comparing patients with melanoma & controls (PMID:18626316)
- SPANX-C gene dosage analysis in Down’s syndrome subjects with undescended testes (PMID:19417550)
- study reports the isolation of AKAP3 and CTp11 Cancer/testis antigens from hepatocellular carcinoma patient sera (PMID:22941507)
- High SPANXC expression is associated with breast cancer invasion. (PMID:26895102)
- Our study examined SPANX-C expression levels in primary uveal melanoma both with and without metastasis to assess if they can be used to predict metastasis. A significantly high expression of SPANX-C was seen in patients with metastasis compared to patients without metastasis. (PMID:31072624)
Cross-species orthologs
0 orthologs
Paralogs (4): SPANXD (ENSG00000196406), SPANXA1 (ENSG00000198021), SPANXA2 (ENSG00000203926), SPANXB1 (ENSG00000227234)
Protein
Protein identifiers
Sperm protein associated with the nucleus on the X chromosome C — Q9NY87 (reviewed: Q9NY87)
Alternative names: Cancer/testis antigen 11.3, Cancer/testis-associated protein CTp11, Nuclear-associated protein SPAN-Xc, SPANX family member C
All UniProt accessions (1): Q9NY87
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm. Nucleus.
Tissue specificity. Detected in testis, melanoma and bladder carcinoma.
Similarity. Belongs to the SPAN-X family.
RefSeq proteins (1): NP_073152* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010007 | SPAN-X_fam | Family |
Pfam: PF07458
UniProt features (7 total): sequence conflict 3, chain 1, region of interest 1, short sequence motif 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NY87-F1 | 68.76 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 14 (showing top):
ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, MAHADEVAN_IMATINIB_RESISTANCE_UP, chrXq27, DALESSIO_TSA_RESPONSE, NOTCH_DN.V1_DN, KRAS.600.LUNG.BREAST_UP.V1_UP, GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP, SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER, GSE2585_THYMIC_MACROPHAGE_VS_MTEC_UP, GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_UP, GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP, GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN, GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_UP, GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
424 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPANXC | GAGE2A | Q6NT46 | 575 |
| SPANXC | XAGE2 | Q96GT9 | 570 |
| SPANXC | GAGE4 | P0DSO3 | 522 |
| SPANXC | SSX1 | Q16384 | 507 |
| SPANXC | FATE1 | Q969F0 | 506 |
| SPANXC | MAGEC2 | Q9UBF1 | 476 |
| SPANXC | XAGE1B | Q9HD64 | 473 |
| SPANXC | SPA17 | Q15506 | 453 |
| SPANXC | MAGEA4 | P43358 | 448 |
| SPANXC | MAGEA1 | P43355 | 446 |
| SPANXC | MAGED4B | Q96JG8 | 446 |
| SPANXC | MAGEB2 | O15479 | 438 |
| SPANXC | MAGEC1 | O60732 | 419 |
| SPANXC | CTAG1A | P78358 | 419 |
| SPANXC | MAGEA2B | P43356 | 419 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SETBP1 | SPANXC | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXC | SETBP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HTT | SPANXC | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXC | ZC3H11A | psi-mi:“MI:0914”(association) | 0.350 |
| PCDHB11 | CLGN | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A087WXM9, A0A1S4GMU2, A0A2K1J5A5, A0A2K1JJ00, A0JM83, A2BIL8, A4IGV6, B4GBA9, F1MF21, H2KZ49, O94542, P24109, P40167, P46012, P46946, Q01030, Q06813, Q0P4S0, Q28DZ0, Q290S5, Q3KQW6, Q3ZBP0, Q4QY64, Q4V7J0, Q5E9A0, Q5M948, Q5M951, Q5MJ08, Q5RCX3, Q5RD08, Q69YH5, Q6AXY9, Q6NWJ0, Q703I1, Q80WR5, Q8IYL3, Q8L7I1, Q93ZL5, Q96QE3, Q9BXN6
Diamond homologs: Q0ZNK1, Q5MJ07, Q5MJ08, Q5MJ09, Q5MJ10, Q5VSR9, Q6SJ82, Q6SJ84, Q6SJ91, Q9BXN6, Q9NS26, Q9NY87, Q9NS25
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
68 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:141242284:T:TA | donor_gain | 0.9600 |
| X:141241751:C:CT | acceptor_gain | 0.9300 |
| X:141242304:T:TA | donor_gain | 0.9300 |
| X:141241752:A:T | acceptor_gain | 0.9200 |
| X:141242302:ATT:A | donor_gain | 0.8500 |
| X:141242285:C:A | donor_gain | 0.8000 |
| X:141242284:TCC:T | donor_gain | 0.7900 |
| X:141242399:T:TA | donor_gain | 0.7600 |
| X:141242421:T:A | donor_gain | 0.7600 |
| X:141242396:A:AA | donor_loss | 0.6900 |
| X:141242397:C:A | donor_loss | 0.6900 |
| X:141242398:C:A | donor_loss | 0.6900 |
| X:141242399:T:A | donor_loss | 0.6900 |
| X:141242238:AG:A | donor_gain | 0.6500 |
| X:141242283:TTC:T | donor_gain | 0.6100 |
| X:141242225:C:T | donor_gain | 0.5600 |
| X:141242427:TC:T | donor_gain | 0.5600 |
| X:141241815:T:TA | donor_gain | 0.5500 |
| X:141242035:C:CT | donor_gain | 0.5200 |
| X:141242219:C:A | donor_gain | 0.5100 |
| X:141242078:C:A | donor_gain | 0.5000 |
| X:141241923:G:GC | donor_gain | 0.4700 |
| X:141242221:C:CT | donor_gain | 0.4600 |
| X:141242222:T:TT | donor_gain | 0.4600 |
| X:141242229:A:C | donor_gain | 0.4400 |
| X:141242032:TAACC:T | donor_gain | 0.4200 |
| X:141242033:AACCA:A | donor_gain | 0.4200 |
| X:141242034:A:C | donor_gain | 0.4000 |
| X:141242217:ACC:A | donor_gain | 0.4000 |
| X:141242218:CCC:C | donor_gain | 0.4000 |
AlphaMissense
643 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:141241550:G:C | F87L | 0.867 |
| X:141241550:G:T | F87L | 0.867 |
| X:141241552:A:G | F87L | 0.867 |
| X:141241581:A:G | I77T | 0.695 |
| X:141242410:A:C | C16W | 0.634 |
| X:141241581:A:C | I77S | 0.632 |
| X:141241640:C:A | R57S | 0.630 |
| X:141241640:C:G | R57S | 0.630 |
| X:141241577:G:C | N78K | 0.622 |
| X:141241577:G:T | N78K | 0.622 |
| X:141241653:A:T | V53D | 0.618 |
| X:141241643:C:A | R56S | 0.609 |
| X:141241643:C:G | R56S | 0.609 |
| X:141241586:G:C | N75K | 0.596 |
| X:141241586:G:T | N75K | 0.596 |
| X:141241648:A:C | Y55D | 0.592 |
| X:141241542:A:G | I90T | 0.587 |
dbSNP variants (sampled 300 via entrez): RS113495682 (X:141241125 T>A), RS1156518244 (X:141243367 T>G), RS1158311197 (X:141243963 A>T), RS1159107824 (X:141240973 C>G), RS1160215750 (X:141244394 G>A), RS1160926899 (X:141242464 T>C,G), RS1160962601 (X:141243543 A>C), RS1161502474 (X:141241744 A>G), RS1163409718 (X:141241340 A>G), RS1164960484 (X:141241876 G>A,T), RS1165947480 (X:141243911 C>A), RS1166751115 (X:141243674 A>G), RS1167805786 (X:141242574 A>AC), RS1167942967 (X:141243065 C>T), RS1168033821 (X:141244187 A>G)
Disease associations
OMIM: gene MIM:300330 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| mercuric bromide | increases expression, affects cotreatment | 2 |
| Benzo(a)pyrene | decreases methylation, increases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, increases expression | 2 |
| methylmercuric chloride | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| tobacco tar | decreases expression | 1 |
| perfluoro-n-nonanoic acid | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Resveratrol | decreases expression, affects cotreatment | 1 |
| Fluorouracil | affects response to substance | 1 |
| Plant Extracts | decreases expression, affects cotreatment | 1 |
| Thiram | increases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Copper Sulfate | affects expression | 1 |
| p-Chloromercuribenzoic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.